Patients older than 50 years, without any significant environmental or occupational exposures and without evidence of any underlying autoimmune disease are very likely to have IPF if the HRCT is felt ...

This progressive lung disease transforms healthy tissue into stiff, scarred areas making breathing difficult. Learn the ...

Endeavor BioMedicines has dosed the first subject in the randomised Phase IIb WHISTLE-PF trial in Australia, assessing the efficacy and safety of ENV-101 (taladegib), an investigational drug for ...